US Stock MarketDetailed Quotes

Eupraxia Pharmaceuticals (EPRX)

Watchlist
  • 7.200
  • -0.200-2.70%
Close Apr 16 16:00 ET
  • 7.340
  • +0.140+1.94%
Post 20:01 ET
442.82MMarket Cap-6.99P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Eupraxia Pharmaceuticals (EPRX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
4.81%-28.55M
-62.87%-9.73M
55.77%-4.51M
-8.05%-8.32M
2.18%-6M
-44.56%-29.99M
1.00%-5.97M
-73.40%-10.19M
-80.15%-7.7M
-34.36%-6.14M
Net income from continuing operations
-49.96%-38.61M
-121.99%-16.72M
-6.31%-6.37M
-44.26%-8.75M
-9.91%-6.77M
11.12%-25.74M
28.99%-7.53M
-22.37%-5.99M
36.21%-6.06M
-55.63%-6.16M
Operating gains losses
1,040.96%1.57M
1,675.81%1.19M
-3,401.09%-328.49K
1,199.81%755.83K
-133.89%-49.11K
330.04%137.48K
-27.73%-75.54K
957.84%9.95K
190.79%58.15K
844.56%144.91K
Depreciation and amortization
38.43%237.72K
33.56%72.81K
66.83%62.99K
31.88%55.43K
24.24%46.49K
10.41%171.72K
32.20%54.51K
-2.47%37.76K
10.25%42.03K
-0.10%37.42K
Other non cash items
-142.15%-76.95K
-17.31%-18.59K
-32.99%-18.92K
-129.79%-20.25K
-113.26%-19.18K
-64.96%182.57K
-110.30%-15.85K
-117.28%-14.23K
-46.29%67.97K
-8.60%144.67K
Change In working capital
89.45%-713.7K
-140.72%-231.59K
135.90%1.7M
48.12%-1.48M
-382.83%-707.4K
-226.40%-6.76M
-89.56%568.72K
-1,446.57%-4.74M
-392.93%-2.84M
117.63%250.12K
-Change in receivables
-325.54%-431.45K
-189.16%-528.27K
-114.43%-7.28K
724.89%112.77K
-150.43%-8.68K
2.24%-101.39K
-47.09%-182.69K
382.61%50.43K
-62.70%13.67K
919.02%17.2K
-Change in prepaid assets
-178.66%-2.64M
-1,127.81%-1.47M
900.99%556.37K
-118.00%-1.93M
56.26%195.64K
-674.63%-948.42K
-1,907.53%-119.41K
-198.29%-69.46K
-270.84%-884.76K
143.49%125.2K
-Change in payables and accrued expense
141.31%2.36M
102.43%1.76M
124.41%1.15M
117.24%340.2K
-930.33%-894.36K
-202.46%-5.71M
-84.39%870.82K
-1,678.03%-4.72M
-268.24%-1.97M
107.32%107.71K
Cash from discontinued investing activities
Operating cash flow
4.81%-28.55M
-62.87%-9.73M
55.77%-4.51M
-8.05%-8.32M
2.18%-6M
-44.56%-29.99M
-0.13%-5.97M
-71.41%-10.19M
-80.15%-7.7M
-34.36%-6.14M
Investing cash flow
Cash flow from continuing investing activities
-683.60%-588.95K
-341.76%-193.3K
-42.82%-60.38K
-1,041.14%-166.23K
-2,389.97%-169.04K
-2.43%-75.16K
11.40%-43.76K
-340.27%-42.28K
379.37%17.66K
15.85%-6.79K
Net PPE purchase and sale
-683.60%-588.95K
-341.76%-193.3K
-42.82%-60.38K
-1,041.14%-166.23K
-2,389.97%-169.04K
-2.43%-75.16K
11.40%-43.76K
-340.27%-42.28K
379.37%17.66K
15.85%-6.79K
Cash from discontinued investing activities
Investing cash flow
-683.60%-588.95K
-341.76%-193.3K
-42.82%-60.38K
-1,041.14%-166.23K
-2,389.97%-169.04K
-2.43%-75.16K
11.40%-43.76K
-340.27%-42.28K
379.37%17.66K
15.85%-6.79K
Financing cash flow
Cash flow from continuing financing activities
66.12%76.06M
-95.30%1.49M
1,706.03%73.9M
105.31%239.78K
-98.14%429.92K
117.20%45.78M
532,658.26%31.73M
-128.25%-4.6M
-198.36%-4.52M
11,805.88%23.17M
Net issuance payments of debt
--0
--0
--0
--0
--0
-11,402.20%-9.14M
--0
-22,915.61%-4.6M
-127,785.50%-4.52M
42.32%-20.55K
Net common stock issuance
35.43%73.89M
--0
--73.89M
--0
--0
243.43%54.56M
--31.71M
--0
--0
--22.85M
Proceeds from stock option exercised by employees
496.99%2.17M
5,664.78%1.49M
--6.79K
--239.78K
27.50%429.92K
-93.11%363.06K
-1.49%25.86K
--0
--0
46.46%337.2K
Cash from discontinued financing activities
Financing cash flow
66.12%76.06M
-95.30%1.49M
1,706.03%73.9M
105.31%239.78K
-98.14%429.92K
117.20%45.78M
532,658.26%31.73M
-128.25%-4.6M
-198.36%-4.52M
11,805.88%23.17M
Net cash flow
Beginning cash position
71.14%33.1M
927.03%88.96M
-15.23%19.77M
-23.54%27.45M
71.14%33.1M
5.90%19.34M
-64.74%8.66M
61.66%23.32M
157.81%35.91M
5.90%19.34M
Current changes in cash
198.56%46.92M
-132.78%-8.43M
567.41%69.33M
32.41%-8.24M
-133.72%-5.74M
6,015.33%15.71M
528.00%25.71M
-243.55%-14.83M
-4,001.35%-12.19M
488.67%17.03M
Effect of exchange rate changes
127.87%544.81K
102.66%33.89K
-176.78%-137.32K
239.01%552.75K
120.73%95.5K
-338.01%-1.96M
-262.18%-1.28M
192.83%178.86K
-317.86%-397.62K
-1,122.24%-460.76K
End cash Position
143.38%80.56M
143.38%80.56M
927.03%88.96M
-15.23%19.77M
-23.54%27.45M
71.14%33.1M
71.14%33.1M
-64.74%8.66M
61.66%23.32M
157.81%35.91M
Free cash flow
3.18%-29.14M
-64.89%-9.92M
55.37%-4.57M
-10.05%-8.48M
-0.47%-6.17M
-44.55%-30.1M
-0.04%-6.02M
-71.84%-10.23M
-80.13%-7.71M
-34.27%-6.14M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 4.81%-28.55M-62.87%-9.73M55.77%-4.51M-8.05%-8.32M2.18%-6M-44.56%-29.99M1.00%-5.97M-73.40%-10.19M-80.15%-7.7M-34.36%-6.14M
Net income from continuing operations -49.96%-38.61M-121.99%-16.72M-6.31%-6.37M-44.26%-8.75M-9.91%-6.77M11.12%-25.74M28.99%-7.53M-22.37%-5.99M36.21%-6.06M-55.63%-6.16M
Operating gains losses 1,040.96%1.57M1,675.81%1.19M-3,401.09%-328.49K1,199.81%755.83K-133.89%-49.11K330.04%137.48K-27.73%-75.54K957.84%9.95K190.79%58.15K844.56%144.91K
Depreciation and amortization 38.43%237.72K33.56%72.81K66.83%62.99K31.88%55.43K24.24%46.49K10.41%171.72K32.20%54.51K-2.47%37.76K10.25%42.03K-0.10%37.42K
Other non cash items -142.15%-76.95K-17.31%-18.59K-32.99%-18.92K-129.79%-20.25K-113.26%-19.18K-64.96%182.57K-110.30%-15.85K-117.28%-14.23K-46.29%67.97K-8.60%144.67K
Change In working capital 89.45%-713.7K-140.72%-231.59K135.90%1.7M48.12%-1.48M-382.83%-707.4K-226.40%-6.76M-89.56%568.72K-1,446.57%-4.74M-392.93%-2.84M117.63%250.12K
-Change in receivables -325.54%-431.45K-189.16%-528.27K-114.43%-7.28K724.89%112.77K-150.43%-8.68K2.24%-101.39K-47.09%-182.69K382.61%50.43K-62.70%13.67K919.02%17.2K
-Change in prepaid assets -178.66%-2.64M-1,127.81%-1.47M900.99%556.37K-118.00%-1.93M56.26%195.64K-674.63%-948.42K-1,907.53%-119.41K-198.29%-69.46K-270.84%-884.76K143.49%125.2K
-Change in payables and accrued expense 141.31%2.36M102.43%1.76M124.41%1.15M117.24%340.2K-930.33%-894.36K-202.46%-5.71M-84.39%870.82K-1,678.03%-4.72M-268.24%-1.97M107.32%107.71K
Cash from discontinued investing activities
Operating cash flow 4.81%-28.55M-62.87%-9.73M55.77%-4.51M-8.05%-8.32M2.18%-6M-44.56%-29.99M-0.13%-5.97M-71.41%-10.19M-80.15%-7.7M-34.36%-6.14M
Investing cash flow
Cash flow from continuing investing activities -683.60%-588.95K-341.76%-193.3K-42.82%-60.38K-1,041.14%-166.23K-2,389.97%-169.04K-2.43%-75.16K11.40%-43.76K-340.27%-42.28K379.37%17.66K15.85%-6.79K
Net PPE purchase and sale -683.60%-588.95K-341.76%-193.3K-42.82%-60.38K-1,041.14%-166.23K-2,389.97%-169.04K-2.43%-75.16K11.40%-43.76K-340.27%-42.28K379.37%17.66K15.85%-6.79K
Cash from discontinued investing activities
Investing cash flow -683.60%-588.95K-341.76%-193.3K-42.82%-60.38K-1,041.14%-166.23K-2,389.97%-169.04K-2.43%-75.16K11.40%-43.76K-340.27%-42.28K379.37%17.66K15.85%-6.79K
Financing cash flow
Cash flow from continuing financing activities 66.12%76.06M-95.30%1.49M1,706.03%73.9M105.31%239.78K-98.14%429.92K117.20%45.78M532,658.26%31.73M-128.25%-4.6M-198.36%-4.52M11,805.88%23.17M
Net issuance payments of debt --0--0--0--0--0-11,402.20%-9.14M--0-22,915.61%-4.6M-127,785.50%-4.52M42.32%-20.55K
Net common stock issuance 35.43%73.89M--0--73.89M--0--0243.43%54.56M--31.71M--0--0--22.85M
Proceeds from stock option exercised by employees 496.99%2.17M5,664.78%1.49M--6.79K--239.78K27.50%429.92K-93.11%363.06K-1.49%25.86K--0--046.46%337.2K
Cash from discontinued financing activities
Financing cash flow 66.12%76.06M-95.30%1.49M1,706.03%73.9M105.31%239.78K-98.14%429.92K117.20%45.78M532,658.26%31.73M-128.25%-4.6M-198.36%-4.52M11,805.88%23.17M
Net cash flow
Beginning cash position 71.14%33.1M927.03%88.96M-15.23%19.77M-23.54%27.45M71.14%33.1M5.90%19.34M-64.74%8.66M61.66%23.32M157.81%35.91M5.90%19.34M
Current changes in cash 198.56%46.92M-132.78%-8.43M567.41%69.33M32.41%-8.24M-133.72%-5.74M6,015.33%15.71M528.00%25.71M-243.55%-14.83M-4,001.35%-12.19M488.67%17.03M
Effect of exchange rate changes 127.87%544.81K102.66%33.89K-176.78%-137.32K239.01%552.75K120.73%95.5K-338.01%-1.96M-262.18%-1.28M192.83%178.86K-317.86%-397.62K-1,122.24%-460.76K
End cash Position 143.38%80.56M143.38%80.56M927.03%88.96M-15.23%19.77M-23.54%27.45M71.14%33.1M71.14%33.1M-64.74%8.66M61.66%23.32M157.81%35.91M
Free cash flow 3.18%-29.14M-64.89%-9.92M55.37%-4.57M-10.05%-8.48M-0.47%-6.17M-44.55%-30.1M-0.04%-6.02M-71.84%-10.23M-80.13%-7.71M-34.27%-6.14M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +6.33%
Sample Name
Sample Code
 +4.40%
Sample Name
Sample Code
 +3.43%
4
United States Gasoline Fund Lp
UGA
+0.46%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
-1.17%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.08%
Sample Name
Sample Code
 +16.18%
Sample Name
Sample Code
 +15.82%
4
Baidu
BIDU
+15.52%
5
Zai Lab
ZLAB
+13.31%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! On the 16th, US President Trump stated that the next round of talks between the US and Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -